| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
82,823,000 |
| Market
Cap: |
1.72(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.92 - $29.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 484 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
60,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$980,094 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
11,539 |
21,539 |
104,169 |
536,685 |
| Total Sell Value |
$248,847 |
$492,446 |
$2,960,641 |
$14,057,583 |
| Total People Sold |
2 |
3 |
4 |
8 |
| Total Sell Transactions |
2 |
3 |
12 |
31 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-10-20 |
4 |
AS |
$9.60 |
$96,000 |
D/D |
(10,000) |
10,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-10-20 |
4 |
OE |
$2.68 |
$26,800 |
D/D |
10,000 |
20,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-10-18 |
4 |
AS |
$9.09 |
$54,556 |
D/D |
(6,000) |
10,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-10-18 |
4 |
OE |
$2.36 |
$14,160 |
D/D |
6,000 |
16,000 |
|
- |
|
| Hall Christopher M |
President and COO |
• – – |
2017-10-02 |
4 |
AS |
$9.00 |
$180,000 |
D/D |
(20,000) |
20,000 |
|
- |
|
| Hall Christopher M |
President and COO |
• – – |
2017-10-02 |
4 |
OE |
$0.80 |
$16,000 |
D/D |
20,000 |
40,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-09-25 |
4 |
AS |
$8.44 |
$50,624 |
D/D |
(6,000) |
10,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-09-25 |
4 |
OE |
$2.36 |
$14,160 |
D/D |
6,000 |
16,000 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2017-08-28 |
4 |
S |
$7.84 |
$19,600 |
I/I |
(2,500) |
279,653 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2017-08-25 |
4 |
S |
$7.81 |
$156,200 |
I/I |
(20,000) |
282,153 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2017-08-24 |
4 |
S |
$7.83 |
$156,600 |
I/I |
(20,000) |
302,153 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2017-08-23 |
4 |
S |
$7.92 |
$158,400 |
I/I |
(20,000) |
322,153 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2017-06-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
6,600 |
342,153 |
|
- |
|
| Treu Jesse I |
Director |
– • – |
2017-05-16 |
4 |
S |
$8.08 |
$17,986 |
I/I |
(2,226) |
20,504 |
|
- |
|
| Treu Jesse I |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,641 |
1,641 |
|
- |
|
| Treu Jesse I |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,642 |
1,642 |
|
- |
|
| Treu Jesse I |
Director |
– • – |
2017-05-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,245) |
0 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-03-21 |
4 |
AS |
$9.09 |
$45,435 |
D/D |
(5,000) |
10,000 |
|
- |
|
| Anderson Bonnie H |
Chairman and CEO |
• • – |
2017-03-21 |
4 |
OE |
$0.80 |
$4,000 |
D/D |
5,000 |
15,000 |
|
- |
|
| Kpcb Xii Associates, Llc |
10% Owner |
– – • |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(750,000) |
2,801,929 |
|
- |
|
| Hall Christopher M |
President and COO |
• – – |
2017-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2016-12-09 |
5 |
GD |
$0.00 |
$0 |
I/I |
14,800 |
348,753 |
|
- |
|
| Jones Evan/ Fa |
Director |
– • – |
2016-12-08 |
5 |
GD |
$0.00 |
$0 |
I/I |
8,050 |
363,553 |
|
- |
|
| Kennedy Keith |
Chief Financial Officer |
• – – |
2016-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Brooks Julie |
EVP, Gen Counsel and Secretary |
• – – |
2016-07-29 |
4 |
A |
$4.21 |
$1,607 |
D/D |
382 |
3,785 |
|
- |
|
524 Records found
|
|
Page 19 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.24 (1.14%) 
